AEPlastic surgeons in the UAE have raised concerns about the growing trend of combining weight-loss medications like Wegovy and Mounjaro with extensive cosmetic procedures such as large breast implants and gluteal augmentations. They warn that rapid weight loss after these surgeries can lead to serious health risks, including skin thinning, dehiscence, and complications during wound healing. The trend is fueled by social media and celebrity culture, pushing for an idealized hourglass figure. Doctors note that the combination of significant weight loss and high-volume implants can result in disproportionate body shapes and increased medical complications. Procedures like AlloClae, which involve injecting fat harvested from donors, are also gaining popularity but lack FDA approval and require strict regulatory oversight. Surgeon Dr. Amina Nabil advises against using weight-loss drugs alongside cosmetic implants due to the heightened risk of adverse effects.
Bias read (Center): While the article discusses a societal and health issue with clear implications for public policy and individual behavior, it does not take a clearly left or right ideological stance. The focus is on medical warnings and health risks rather than political advocacy or partisan commentary. The framing
